Bachem Holding AG (SWX:BANB)
Switzerland · Delayed Price · Currency is CHF 76.95
-2.35 (-2.96%)
Sep 11, 2026, 5:30 PM CET
Bachem Holding AG Market Cap
Bachem Holding AG has a market cap or net worth of 5.77 billion as of September 11, 2026. Its market cap has increased by 23.25% in one year.
Market Cap
5.77B
Enterprise Value
5.92B
Revenue
708.53M
Ranking
n/a
PE Ratio
38.79
Stock Price
76.95
ChartMarket Cap Chart
Since March 1, 1999, Bachem Holding AG's market cap has increased from 1.52B to 5.77B, an increase of 278.63%. That is a compound annual growth rate of 4.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 5.77B | 28.40% |
| Dec 30, 2025 | 4.49B | 3.45% |
| Dec 30, 2024 | 4.34B | -10.92% |
| Dec 29, 2023 | 4.87B | -17.25% |
| Dec 30, 2022 | 5.89B | -44.23% |
| Dec 30, 2021 | 10.56B | 90.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Idorsia | 1.35B |
| Basilea Pharmaceutica AG | 800.98M |
| Santhera Pharmaceuticals Holding AG | 259.67M |
| Newron Pharmaceuticals | 252.58M |
| BioVersys AG | 167.16M |
| Molecular Partners AG | 131.00M |
| Xlife Sciences AG | 74.13M |
| MindMaze Therapeutics Holding | 30.56M |